[go: up one dir, main page]

BR9611448A - Combinação de glibenclamida-metformina para o tratamento de diabetes melito do tipo ii - Google Patents

Combinação de glibenclamida-metformina para o tratamento de diabetes melito do tipo ii

Info

Publication number
BR9611448A
BR9611448A BR9611448A BR9611448A BR9611448A BR 9611448 A BR9611448 A BR 9611448A BR 9611448 A BR9611448 A BR 9611448A BR 9611448 A BR9611448 A BR 9611448A BR 9611448 A BR9611448 A BR 9611448A
Authority
BR
Brazil
Prior art keywords
glibenclamide
diabetes mellitus
treatment
type
metformin combination
Prior art date
Application number
BR9611448A
Other languages
English (en)
Inventor
Regis Massimo De
Giulio Barelli
Original Assignee
Abiogen Pharma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11372517&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR9611448(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abiogen Pharma Srl filed Critical Abiogen Pharma Srl
Publication of BR9611448A publication Critical patent/BR9611448A/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/64Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BR9611448A 1995-11-14 1996-11-07 Combinação de glibenclamida-metformina para o tratamento de diabetes melito do tipo ii BR9611448A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI002337A IT1276130B1 (it) 1995-11-14 1995-11-14 Associazione glibenclamide-metformina, composizioni farmaceutiche che la contengono e loro uso nel trattamento del diabete mellito di tipo
PCT/EP1996/004860 WO1997017975A1 (en) 1995-11-14 1996-11-07 A glibenclamide-metformin combination for the treatment of diabetes mellitus of type ii

Publications (1)

Publication Number Publication Date
BR9611448A true BR9611448A (pt) 1999-03-23

Family

ID=11372517

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611448A BR9611448A (pt) 1995-11-14 1996-11-07 Combinação de glibenclamida-metformina para o tratamento de diabetes melito do tipo ii

Country Status (11)

Country Link
US (2) US5922769A (pt)
EP (1) EP0869796B1 (pt)
AT (1) ATE238802T1 (pt)
AU (1) AU7566896A (pt)
BR (1) BR9611448A (pt)
DE (2) DE69627883T2 (pt)
DK (1) DK0869796T3 (pt)
ES (1) ES2150889T3 (pt)
IT (1) IT1276130B1 (pt)
PT (1) PT869796E (pt)
WO (1) WO1997017975A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291495B1 (en) 1997-02-24 2001-09-18 Robert B. Rieveley Method and composition for the treatment of diabetes
CA2312990C (en) * 1997-12-08 2008-04-29 Bristol-Myers Squibb Company Novel salts of metformin and method
US6099859A (en) * 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
ATE250418T1 (de) * 1998-07-15 2003-10-15 Merck Sante Sas Tabletten enthaltend eine kombination von glibenclamid und metformin
US6099862A (en) * 1998-08-31 2000-08-08 Andrx Corporation Oral dosage form for the controlled release of a biguanide and sulfonylurea
AU753933B2 (en) * 1998-09-18 2002-10-31 The, Yong Telephonic transaction system
US6958324B2 (en) * 1998-12-02 2005-10-25 Inotek Pharmaceuticals Corporation Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
US7056539B2 (en) 1999-03-12 2006-06-06 Vladimir Leko Process and product extracted from herbal composition useful in controlling diabetes mellitus type II
JP2003520759A (ja) * 1999-08-31 2003-07-08 アンドルックス ファーマスーティカルズ インコーポレーテッド 単位核を有する徐放性錠剤
RU2275915C2 (ru) * 1999-11-03 2006-05-10 Бристол-Маерс Сквибб Компани Способ лечения диабета
US6586438B2 (en) * 1999-11-03 2003-07-01 Bristol-Myers Squibb Co. Antidiabetic formulation and method
US20010036479A1 (en) * 2000-01-14 2001-11-01 Gillian Cave Glyburide composition
AU2001229601A1 (en) * 2000-01-24 2001-07-31 Inotek Corporation Method and composition for modulating an immune response
WO2002028181A1 (en) * 2000-10-02 2002-04-11 Usv Limited Sustained release pharmaceutical compositions containing metformin and method of its production
US6866866B1 (en) * 2000-11-03 2005-03-15 Andrx Labs, Llc Controlled release metformin compositions
US20060034922A1 (en) * 2000-11-03 2006-02-16 Andrx Labs, Llc Controlled release metformin compositions
FR2816840B1 (fr) * 2000-11-17 2004-04-09 Flamel Tech Sa Medicament a base de microcapsules d'anti-hyperclycemiant a liberation prolongee et son procede de preparation
FR2816841B1 (fr) * 2000-11-22 2004-02-06 Lipha Nouvelles compositions pharmaceutiques a action antidiabetique et leur procede de preparation
JP4633329B2 (ja) 2001-01-12 2011-02-16 サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド スペーストドラッグデリバリーシステム
RU2351317C2 (ru) * 2001-01-12 2009-04-10 Сан Фармасьютикал Индастриз Лимитед Система раздельной доставки лекарственных средств
PT1377276E (pt) * 2001-04-10 2011-12-30 Sun Pharma Advanced Res Co Ltd Composição de libertação temporizada por pulso
FR2825023B1 (fr) * 2001-05-23 2005-04-15 Flamel Tech Sa Forme pharmaceutique orale antidiabetique "une prise par jour"comprenant une biguanide et au moins un autre principe actif
NZ530990A (en) * 2001-08-31 2005-08-26 Australian Biomedical Company Preparation and diabetic use of gibberellins
EP1435931A2 (en) * 2001-09-28 2004-07-14 Sun Pharmaceuticals Industries Ltd. Dosage form for treatment of diabetes mellitus
FR2830447B1 (fr) * 2001-10-09 2004-04-16 Flamel Tech Sa Forme galenique orale microparticulaire pour la liberation retardee et controlee de principes actifs pharmaceutiques
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
ITFI20010230A1 (it) * 2001-11-29 2003-05-29 Menarini Int Operations Lu Sa Composizioni farmaceutiche per il trattamento del diabete mellito di tipo ii
US7183321B2 (en) * 2001-12-17 2007-02-27 Bristol-Myers Squibb Company Antidiabetic formulation and method
DE60219963T2 (de) 2002-01-25 2008-02-07 Laboratorios Silanes, S.A. De C.V. Pharmazeutische zusammensetzung, die zur glukosekontrolle im blut von patienten mit diabetes typ 2 eingesetzt wird
US6682759B2 (en) 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
WO2003068209A1 (en) * 2002-02-14 2003-08-21 Sonus Pharmaceuticals, Inc. Metformin salts of lipophilic acids
US7811593B2 (en) * 2002-03-25 2010-10-12 Jian Luo Pharmaceutical composition with combined active agents and methods for using the same
KR20050005437A (ko) * 2002-04-09 2005-01-13 플라멜 테크놀로지스 아목시실린의 변형 방출을 위한 마이크로캡슐 수성 현탁액형태의 경구 제약학적 제제
EP1492511B3 (fr) 2002-04-09 2012-05-02 Flamel Technologies Formulation pharmaceutique orale sous forme de suspension aqueuse de microcapsules permettant la liberation modifiee de principe(s) actif(s)
AU2002356419A1 (en) 2002-06-17 2003-12-31 Themis Laboratories Private Limited Multilayer tablets containing thiazolidinedione and biguanides and methods for producing them
JP2005537298A (ja) 2002-08-02 2005-12-08 ペンウェスト ファーマシューティカルズ カンパニー メトホルミンの徐放性製剤
FR2853831A1 (fr) * 2003-03-05 2004-10-22 Usv Ltd Forme posologique solide a usage oral de metformine et de glyburide et son procede de preparation
WO2004108067A2 (en) * 2003-04-03 2004-12-16 Sun Pharmaceutical Industries Limited Programmed drug delivery system
US20050013863A1 (en) * 2003-07-18 2005-01-20 Depomed, Inc., A Corporation Of The State Of California Dual drug dosage forms with improved separation of drugs
AU2005284798B2 (en) * 2004-09-15 2012-02-02 The President And Fellows Of Harvard College Reducing ER stress in the treatment of obesity and diabetes
US20060073213A1 (en) * 2004-09-15 2006-04-06 Hotamisligil Gokhan S Reducing ER stress in the treatment of obesity and diabetes
JOP20180109A1 (ar) * 2005-09-29 2019-01-30 Novartis Ag تركيبة جديدة
FR2896157B1 (fr) 2006-01-13 2008-09-12 Merck Sante Soc Par Actions Si Combinaison de derives de triazine et d'agents de stimulation de secretion d'insuline.
WO2008062273A2 (en) * 2006-11-20 2008-05-29 Cadila Pharmaceuticals Limited Solid oral dosage form having antidiabetic drug combination
CN105030793A (zh) * 2015-08-25 2015-11-11 瑞阳制药有限公司 二甲双胍格列本脲胶囊及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2325581A1 (de) 1973-05-19 1974-12-05 Hoechst Ag Partiell hydrierte 1h-indeno eckige klammer auf 1,2-b eckige klammer zu -pyridin-derivate und verfahren zu ihrer herstellung
JPS5936885B2 (ja) 1976-06-24 1984-09-06 第一製薬株式会社 糖尿病治療剤
DE2720926C2 (de) 1977-05-10 1983-02-17 Hoechst Ag, 6000 Frankfurt Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
GB8613688D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
GB8613689D0 (en) 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US5260275A (en) 1990-08-14 1993-11-09 Amylin Pharmaceuticals, Inc. Hypoglycemics
JP3338119B2 (ja) 1993-04-14 2002-10-28 呉羽化学工業株式会社 抗糖尿病剤

Also Published As

Publication number Publication date
ES2150889T1 (es) 2000-12-16
US5922769A (en) 1999-07-13
ATE238802T1 (de) 2003-05-15
DE69627883D1 (de) 2003-06-05
ITMI952337A1 (it) 1997-05-14
EP0869796A1 (en) 1998-10-14
DK0869796T3 (da) 2003-08-18
AU7566896A (en) 1997-06-05
PT869796E (pt) 2003-09-30
USRE37330E1 (en) 2001-08-14
ITMI952337A0 (pt) 1995-11-14
HK1011525A1 (en) 1999-07-16
EP0869796B1 (en) 2003-05-02
DE869796T1 (de) 2001-04-19
ES2150889T3 (es) 2004-01-01
WO1997017975A1 (en) 1997-05-22
IT1276130B1 (it) 1997-10-27
DE69627883T2 (de) 2004-05-19

Similar Documents

Publication Publication Date Title
BR9611448A (pt) Combinação de glibenclamida-metformina para o tratamento de diabetes melito do tipo ii
BR8901053A (pt) Regulador de pressao,e combinacao de valvula/regulador
ES2159184T3 (es) Nueva posologia para la dmni.
ES2143534T3 (es) Cartucho revelador y metodo de rehabilitacion del mismo.
ZA872690B (en) Synergistic combination of amantadine and selegiline
DE3675452D1 (de) Folientastatur mit piezoelektrischen tasten.
AR243412A1 (es) Un catalizador para la oxidacion de compuestos azufrados presentes en los efluentes gaseosos y el procedimiento de tratamiento de dichos efluentes con dicho catalizador.
GB9603325D0 (en) A compound
MX9100361A (es) Metodos para reducir sulfuros en gas de aguas negras
DE4391636T1 (de) Betriebsventilanordnung mit Druckausgleichsventil
DE59008501D1 (de) Neue, stickstoffhaltige Titanocene und deren Verwendung.
DE58904713D1 (de) Verwendung von zink- oder eisenhydroxid zur adjuvierung von antigenloesungen und auf diese weise adjuvierte antigenloesungen.
NO853034L (no) Stempelaktivert kjemikalieinnspr¯ytningsventil.
NO900057L (no) Bokslokk som er lett aa aapne.
DE3463579D1 (en) Watch case
BR9407426A (pt) Processo para a preparaçao de 9-(2-hidróxi)-etoximetil- guanina
NO892657L (no) Blandinger oppnaadd med hydroksyimidazoliner og polyaminerog anvendelse derav som additiver for motorbrensel.
DE69416274D1 (de) Druckzylinder und elastische druckplatte für diesen druckzylinder
IT1223019B (it) Valvola a cerniera tollerante i frammenti
ZA891242B (en) 24r-scymnol,and preparation and use thereof
DE68917944D1 (de) O.R.I.-gehemmte Motorbrennstoffzusammensetzung, und einlagerungsbeständiges Konzentrat.
DE69218739D1 (de) Sicherheitsventil mit flacher Elastomerdichtung
DE68920489D1 (de) Sicherheits- und Regulierventil für Gas.
DE59101547D1 (de) Stoffgemische für Absorptionswärmepumpen and Absorptionswärmetransformatoren.
BR6801635U (pt) Canopla com tecla removivel para valvulas de descarga

Legal Events

Date Code Title Description
TC Change of name
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: OPINO PELO INDERFERIMENTO DO PEDIDO, PRESENTE COM BASE NO ARTIGO 37 DA LEI 9.279 DE 14/05/1996 COMBINADO O ARTIGO 229-A DA LEI 10.196 DE 14/02/2001.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 10A E 11A ANUIDADES.

B08H Application fees: decision cancelled [chapter 8.8 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1917 DE 02/10/2007 POR TER SIDO INDEVIDO.

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL.